|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 23, 2017 ) Alopecia is the partial or complete loss of hair especially on the scalp either in patches on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies irritants toxins burns injuries and infections.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Alopecia-Pipeline Review H2 2017 provides comprehensive information on the therapeutics under development for Alopecia (Dermatology) complete with analysis by stage of development drug target mechanism of action (MoA) route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics its complete research and development history and latest news and press releases.
The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes the molecules developed by Companies in Pre-Registration Phase III Phase II Phase I IND/CTA Filed Preclinical and Discovery stages are 1 1 12 5 1 19 and 9 respectively. Similarly the Universities portfolio in Phase III and Discovery stages comprises 1 and 1 molecules respectively.
Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases company/university websites clinical trial registries conferences SEC filings investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis..
For more information about this report at http://www.reportsweb.com/alopecia-pipeline-review-h2-2017
Report Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology) .
- The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise product description descriptive licensing and collaboration details R&D brief MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA) drug target route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology)
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001881442/sample
Reasons to buy
- Procure strategically important competitor information analysis and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology) .
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Key Company profiles
Aclaris Therapeutics Inc
Allergan Plc
Almirall SA
AndroScience Corp
Berg LLC
BiologicsMD Inc
BirchBioMed Inc
Brickell Biotech Inc
Bristol-Myers Squibb Company
Cassiopea SpA
Daewoong Pharmaceutical Co Ltd
Dong-A Socio Holdings Co Ltd
Handok Inc
Ask for Discount at http://www.reportsweb.com/inquiry&RW0001881442/discount
List of Tables
Number of Products under Development for Alopecia H2 2017
Number of Products under Development by Companies H2 2017
Number of Products under Development by Companies H2 2017 (Contd..1) H2 2017
Number of Products under Development by Universities/Institutes H2 2017
Products under Development by Companies H2 2017
Products under Development by Companies H2 2017 (Contd..1) H2 2017
Products under Development by Companies H2 2017 (Contd..2) H2 2017
Products under Development by Universities/Institutes H2 2017
Number of Products by Stage and Target H2 2017
Number of Products by Stage and Target H2 2017 (Contd..1) H2 2017
Number of Products by Stage and Mechanism of Action H2 2017
Number of Products by Stage and Mechanism of Action H2 2017 (Contd..1) H2 2017
Number of Products by Stage and Route of Administration H2 2017
Number of Products by Stage and Molecule Type H2 2017
Alopecia-Pipeline by Aclaris Therapeutics Inc H2 2017
Alopecia-Pipeline by Allergan Plc H2 2017
Alopecia-Pipeline by Almirall SA H2 2017
Alopecia-Pipeline by AndroScience Corp H2 2017
Alopecia-Pipeline by Berg LLC H2 2017
Alopecia-Pipeline by BiologicsMD Inc H2 2017
Alopecia-Pipeline by BirchBioMed Inc H2 2017
Alopecia-Pipeline by Brickell Biotech Inc H2 2017
Alopecia-Pipeline by Bristol-Myers Squibb Company H2 2017
Alopecia-Pipeline by Cassiopea SpA H2 2017
Purchase Complete Report at http://www.reportsweb.com/buy&RW0001881442/buy/2000
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
